Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises A3P Biomedical in conjunction with directed share issue
Mandate

Vinge advises A3P Biomedical in conjunction with directed share issue

May 05, 2022 M&A

Vinge has advised A3P Biomedical in connection with an issue of shares amounting to SEK 400 million directed at Stena Sessan AB, TomEqt Private AB, Flerie Invest AB, Östersjöstiftelsen and Inbox Capital. A3P Biomedical specialises in advanced diagnostics of prostate cancer.

Vinge’s team primarily consisted of Johan Winnerblad, Rikard Lindahl, William Kåge, Lorin Arabi, Gabriel Chabo, Stojan Arnerstål, Arvid Axelryd and Olivia Belding.

Related

Vinge advises on the sale of Compab to Tången

 Vinge has advised the owners of Compab Energiteknik in connection with the sale of 80 per cent of the shares to Tången Industrikapital. Compab, which has a turnover of approximately SEK 100 million, sells, installs and services, amongst other things, steam and hot-water boilers as well as burners for the industrial sector.
October 26, 2026

Vinge advises Capio on the acquisition of Rehabhotellet Sthlm AB

 Rehabhotellet i Sthlm AB provides advanced home healthcare and specialized inpatient palliative care within the Stockholm Region.
October 26, 2026

Vinge advises Ikano Bank on acquisition of loan portfolio from Entercard

 Vinge has advised Ikano Bank AB (publ) on the acquisition of a portfolio of performing consumer loans from Entercard Group AB. As at 30 September 2026, the contractual amount of the loans totalled approximately SEK 7 billion.
October 26, 2026